Browse EX-10 agreements

Conexeu Sciences Inc.: Exhibit 10.5 - Filed by newsfilecorp.com

---

CONEXEU SCIENCES BOARD COMPENSATION NOTICE Effective June 15, 2026

Dear Jeff Sharpe,

On behalf of Conexeu Sciences, Inc., I am pleased to confirm the updated terms of your compensation as a member of the Board of Directors, effective June 15, 2026.

1.  Board Role

Name: Jeff Sharpe

Role: Chairman of the Board of Directors

Effective Date: June 15, 2026

 

2.  Committee Assignments

As Board Chairman, you serve on all committees in an ex officio advisory capacity. Committee-specific fees do not apply to the Board Chair role.

3.  Annual Compensation

Compensation Element

Annual Amount

Payment

Base Board Retainer

$50,000

Quarterly in arrears

Board Chair Premium

$50,000

Quarterly in arrears

Annual RSU Grant

$150,000

Annually on June 15

TOTAL ANNUAL COMPENSATION

$250,000

 

Total Annual Compensation (cash + equity):  $250,000

4.  Annual Equity Grant

…

Conexeu Sciences Inc.: Exhibit 10.3 - Filed by newsfilecorp.com

---

CERTAIN IDENTIFIED INFOMRATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

CONEXEU SCIENCES BOARD MEMBER AGREEMENT

This Board Member Agreement ("Agreement") is made and entered into as of June 15, 2026 (the "Effective Date"), by and between Conexeu Sciences Inc., a Nevada corporation (the "Company") having offices at 50 West Liberty Street, Suite 880 Reno Nevada, USA 89501, and Andrew Costa, located at [****] ("Board Member").

1. Appointment and Term

1.1 Appointment

The Company hereby appoints the Board Member to serve on its Board of Directors (the "Board") effective as of the Effective Date.

1.2 Term

The Board Member shall serve until the earlier of resignation, removal or the next annual meeting of stockholders.

2. Duties and Responsibilities

2.1 General Duties

…

Conexeu Sciences Inc.: Exhibit 10.7 - Filed by newsfilecorp.com

---

CONEXEU SCIENCES BOARD COMPENSATION NOTICE Effective June 15, 2026

Dear Dr. Aaron Farberg,

On behalf of Conexeu Sciences, Inc., I am pleased to confirm the updated terms of your compensation as a member of the Board of Directors, effective June 15, 2026.

1.  Board Role

Name:            Aaron Farberg

Role:              Non-Employee Director

Effective Date: June 15, 2026

 

2.  Committee Assignments

•  Audit Committee: Chair (outgoing - through June 14, 2026), Member (effective June 15, 2026) •  N&G Committee: Chair (effective June 15, 2026) •  Compensation Committee: Chair (outgoing - through June 14, 2026)

 

3.  Annual Compensation

Compensation Element

Annual Amount

Payment

Base Board Retainer

$50,000

Quarterly in arrears

Audit Committee - Member

$7,500

Quarterly in arrears

N&G Committee - Chair

$7,500

Quarterly in arrears

Annual RSU Grant

$100,000

Annually on June 15

TOTAL ANNUAL COMPENSATION

$165,000

…

Conexeu Sciences Inc.: Exhibit 10.2 - Filed by newsfilecorp.com

---

CERTAIN IDENTIFIED INFOMRATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

CONEXEU SCIENCES BOARD MEMBER AGREEMENT

This Board Member Agreement ("Agreement") is made and entered into as of June 15, 2026 (the "Effective Date"), by and between Conexeu Sciences Inc., a Nevada corporation (the "Company") having offices at 50 West Liberty Street, Suite 880 Reno Nevada, USA 89501, and Ana Bastiani-Posner, located at [****] ("Board Member").

1. Appointment and Term

1.1 Appointment

The Company hereby appoints the Board Member to serve on its Board of Directors (the "Board") effective as of the Effective Date.

1.2 Term

The Board Member shall serve until the earlier of resignation, removal or the next annual meeting of stockholders.

2. Duties and Responsibilities

2.1 General Duties

…

Conexeu Sciences Inc.: Exhibit 10.8 - Filed by newsfilecorp.com

---

CONEXEU SCIENCES INC.

EXECUTIVE EMPLOYMENT AGREEMENT

This Executive Employment Agreement (the "Agreement") is made and entered into as of June 15, 2026, (the "Effective Date"), by and between Conexeu Sciences Inc., a Reno, Nevada based company (the "Company"), and David Bogart (the "Executive"). The Company and the Executive are sometimes referred to individually as a "Party" and collectively as the "Parties."

…

Conexeu Sciences Inc.: Exhibit 10.1 - Filed by newsfilecorp.com

---

CERTAIN IDENTIFIED INFOMRATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

CONEXEU SCIENCES BOARD MEMBER AGREEMENT

This Board Member Agreement ("Agreement") is made and entered into as of June 15, 2026 (the "Effective Date"), by and between Conexeu Sciences Inc., a Nevada corporation (the "Company") having offices at 50 West Liberty Street, Suite 880 Reno Nevada, USA 89501, and April Burke, located at [****] ("Board Member").

1. Appointment and Term

1.1 Appointment

The Company hereby appoints the Board Member to serve on its Board of Directors (the "Board") effective as of the Effective Date.

1.2 Term

The Board Member shall serve until the earlier of resignation, removal or the next annual meeting of stockholders.

2. Duties and Responsibilities

2.1 General Duties

…

Conexeu Sciences Inc.: Exhibit 10.4 - Filed by newsfilecorp.com

---

CONEXEU SCIENCES BOARD COMPENSATION NOTICE Effective June 15, 2026

Dear Dr. Lorenc,

On behalf of Conexeu Sciences, Inc., I am pleased to confirm the updated terms of your compensation as a member of the Board of Directors, effective June 15, 2026.

1.  Board Role

Name: Dr. Z. Paul Lorenc

Role: Non-Employee Director

Effective Date: June 15, 2026

 

2.  Committee Assignments

•  Compensation Committee: Member •  N&G Committee: Member

 

3.  Annual Compensation

Compensation Element

Annual Amount

Payment

Base Board Retainer

$50,000

Quarterly in arrears

Compensation Committee - Member

$6,000

Quarterly in arrears

N&G Committee - Member

$5,000

Quarterly in arrears

Annual RSU Grant

$100,000

Annually on June 15

TOTAL ANNUAL COMPENSATION

$161,000

 

Total Annual Compensation (cash + equity): $161,000

4.  Annual Equity Grant

…

---

Exhibit 10.11

 

SETTLEMENT AGREEMENT AND MUTUAL RELEASE

 

This Settlement Agreement and Mutual Release (this "Agreement") is entered into as of June 8, 2026 (the "Effective Date"), by and between:

 

(1) DevvStream Corp., a company organized and existing under the laws of the Province of Alberta, Canada (the "Company" or "DEVS"); and

 

(2) Helena Global Investment Opportunities 1 Ltd., ("Helena," and together with the Company, the "Parties," and each, a "Party").

 

RECITALS

 

WHEREAS, on July 17, 2025, the Company issued a Convertible Promissory Note (the "Note") in favor of Helena, pursuant to which Helena extended financing to the Company, and the Parties entered into a related Securities Purchase Agreement (the "Purchase Agreement"), a Security Agreement (the "Security Agreement") and certain other Transaction Documents (as defined in the Purchase Agreement) of even date (collectively with the Note, the "Transaction Documents");

…

---

Exhibit 10.10

 

CONFIDENTIAL – INDICATIVE TERM SHEET

Series A Non-Redeemable Convertible Preferred Stock

 

This binding term sheet (this “Term Sheet”), dated effective as of June 3, 2026, summarizes the principal terms of a proposed private placement (the “Transaction”) of Series A Non-Redeemable Convertible Preferred Stock of DevvStream Corp. (the “Company”) to EEME Energy SPV I, LLC (the “Investor”). Note: this security is intended to qualify as permanent equity under U.S. GAAP.

 

Notwithstanding the foregoing, the undersigned parties acknowledge and agree that (i) this Term Sheet is intended to and shall be binding upon each of them as of the date hereof to the extent provided herein, and (ii) until this Term Sheet is terminated in accordance with its terms, each of them will use its commercially reasonable efforts, in good faith, to complete due diligence, memorialize the Transaction and other arrangements effectuated hereby.

…

AMENDED AND RESTATED EMPLOYMENT AGREEMENT FOR HUSSEIN SWEITI

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between enGene USA, Inc., its successors and assigns (the “Company”) and Hussein Sweiti (the “Executive”) as of the date first written below.

WHEREAS, the Company and the Executive previously entered into an Employment Agreement dated as of September 29, 2025 (“September 29, 2025 Agreement”); and

WHEREAS, the Company has determined that it is in the best interest of the Company to continue the services and employment of the Executive as its Chief Medical Officer and the Executive desires to serve in such capacity on behalf of the Company.

NOW, THEREFORE, in consideration of the premises and of the mutual covenants and agreements hereinafter set forth, the Company and the Executive hereby agree as follows:

Employment.

(a)

…

SECOND AMENDED & RESTATED EMPLOYMENT AGREEMENT

FOR ANTHONY CHEUNG

 

THIS SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of February 27, 2026, by and between enGene Inc. (the “Company”) and Anthony Cheung (the “Executive”).

 

WHEREAS, the Company and the Executive previously entered into an Employment Agreement dated November 8, 2023 (“November 8, 2023 Agreement”);

 

WHEREAS, the Company and the Executive previously entered into an Amended & Restated Employment Agreement dated October 16, 2024 (“October 16, 2024 Agreement”);

 

WHEREAS, the Company has determined that it is in the best interest of the Company to continue the services and employment of the Executive as its Chief Scientific Officer, and the Executive is willing to render such services on the terms and conditions set forth herein; and

 

WHEREAS, the parties desire to amend and restate the October 16, 2024 Agreement to reflect such terms and conditions as set forth herein this Agreement.

…

Document

EXHIBIT 10.2

FINAL TEMPLATE (2026)

###EMPLOYEE_GRANT_NUMBER###

  

RESTRICTED STOCK AWARD AGREEMENT PURSUANT TO THE COMTECH TELECOMMUNICATIONS CORP. 2023 EQUITY AND INCENTIVE PLAN

 

Dear ###PARTICIPANT_NAME###: 

Preliminary Statement

As a non-employee director of Comtech Telecommunications Corp. (the “Company”), pursuant to Section 3.1 of the Comtech Telecommunications Corp. 2023 Equity and Incentive Plan (the “Plan”), you were granted on ###GRANT_DATE### (the “Grant Date”), pursuant to the terms of the Plan and this Restricted Stock Award Agreement (this “Agreement”), the number of shares of Restricted Stock set forth below.

The terms of the grant are as follows:

          1.          Grant of Restricted Stock.  Subject in all respects to the Plan and the terms and conditions set forth herein and therein, on the Grant Date you were granted ###TOTAL_AWARDS### shares of Restricted Stock (the “Award”).

…